Tansna Therapeutics, Inc., is a drug discovery and development company focused on novel therapies for the treatment of CNS disorders, with an initial focus on epilepsy.  The company has identified a library of proprietary compounds that are derivatives of the marketed anesthetic propofol.  These compounds are drug-like small-molecules, exhibit broad-spectrum CNS pharmacology, and are non-sedating.

Venture Information
Stage: 
Pre-Clinical
Company Information
Company Location: 
St. Louis, MO